๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 163 Guangzhou 7 Nanjing 5 Harbin 4 Suzhou 4
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84 Clear sponsor filter
Site location
Shanghai163 Guangzhou7 Nanjing5 Harbin4 Suzhou4
All 40 locations
Target enrolment
to

Trials with a site in Shanghai

163 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Positive- vs Negative-Pressure Extubation in High-Risk Patients
NCT07829627Positive Pressure Extubation Techniques, Negative Pressure Extubation Techniques, High-risk Patients Prone to Extubation Failure
Shanghai Zhongshan Hospital
Not applicable
96
Shanghai
2026-11-01
Not yet open
Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma
NCT07812467Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Shanghai Zhongshan Hospital
Phase 2
220
Shanghai
2026-10-01
Not yet open
Physician-Supervised GPT Assistance for Communicating Cardiopulmonary Exercise Test Results
NCT07829731Clinical Decision Support Systems, Cardiopulmonary Exercise Testing
Shanghai Zhongshan Hospital
Not applicable
80
Shanghai
2026-09-23
Recruiting
TEE-Guided Versus CCTA-Guided Preprocedural Imaging for Left Atrial Appendage Closure
NCT07815119Nonvalvular Atrial Fibrillation
Shanghai Zhongshan Hospital
Not applicable
590
Shanghai
2026-09-01
Recruiting
A Prospective Observational Study Using the FAM-CAM
NCT07694687Patients in ICU, Delirium in the Intensive Care Unit, Family
Shanghai Zhongshan Hospital
Observational
330
Shanghai
2026-08-01
Not yet open
Eye Tracking for Early Identification of Post-ICU Cognitive Impairment
NCT07676864Post Intensive Care Syndrome (PICS), Cognitive Impairment
Shanghai Zhongshan Hospital
Observational
73
Shanghai
2026-08
Not yet open
The Efficacy and Safety of Donafenib Plus PD-1/L1 Monoclonal Antibodies Plus TACE or HAIC as First-line Treatment for Unresectable Hepatocellular Carcinoma A Multi-center, Retrospective Clinical Study
NCT07724951Hepatocellular Carcinoma (HCC)
Shanghai Zhongshan Hospital
Observational
400
Guangzhou, Nanning, Harbin, Qingdao, Shanghai, Kunming
2026-07-31
Recruiting
QL1706๏ผˆIparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract Cancer
NCT07733115Biliary Tract Cancer (BTC)
Shanghai Zhongshan Hospital
Phase 2
38
Shanghai
2026-07-20
Recruiting
Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation
NCT07677410Aortic Regurgitation Disease
Shanghai Zhongshan Hospital
Not applicable
1,172
Shanghai
2026-07-18
Not yet open
Ertugliflozin's Effect on Heart Function in Diabetic Patients After Myocardial Infarction
NCT07621380Type 2 Diabetes Mellitus Myocardial Infarction
Shanghai Zhongshan Hospital
Phase 4
476
Shanghai
2026-07-01
Not yet open
EIT-Guided Visual Feedback During Incentive Spirometry for Postoperative Atelectasis
NCT07681232Postoperative Atelectasis
Shanghai Zhongshan Hospital
Not applicable
60
Shanghai
2026-07-01
Recruiting
Evaluating a Text-Prompt AI Assistant for Chest CT Scans (AI-REPORT Study)
NCT07634861Thoracic Diseases
Shanghai Zhongshan Hospital
Not applicable
100
Shanghai
2026-06-20
Active, closed
ICCA-Based ICU Physiological State Space Monitor
NCT07773571Critical Illness
Shanghai Zhongshan Hospital
Observational
60,000
Shanghai
2026-06-15
Recruiting
ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight Management
NCT07517042Obesity, Weight Control
Shanghai Zhongshan Hospital
Not applicable
420
Chongqing, Fuzhou, Xiamen, Wuhan, Nanjing, Suzhou, Shanghai, Luzhou
2026-06-10
Not yet open
Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment
NCT07508956Gastric / Gastroesophageal Junction Adenocarcinoma
Shanghai Zhongshan Hospital
Phase 3
304
Shanghai
2026-06-01
Not yet open
Intravascular Ultrasound guidaNce versuS angIoGrapHy Guidance in Patients With ST-segment Elevation Myocardial Infarction
NCT07616024STEMI, PCI
Shanghai Zhongshan Hospital
Not applicable
2,488
Shanghai
2026-06-01
Not yet open
SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer
NCT07535632Colorectal Neoplasms
Shanghai Zhongshan Hospital
Phase 2
58
Shanghai
2026-06-01
Not yet open
Direct Oral Novel Anticoagulants for Patients With High-risk Gastroesophageal Variceal Bleeding and Portal Vein Thrombosis
NCT07602062Portal Vein Thrombosis, Anticoagulant Therapy, Variceal Bleeding
Shanghai Zhongshan Hospital
Not applicable
175
Shanghai
2026-06-01
Not yet open
AI-Assisted Chest-CT Reporting for Enhanced Speed and Quality (The DOUBLE-ACE Study)
NCT07640906Thoracic Diseases, Chest CT Scan, Artificial Intelligence (AI) in Diagnosis
Shanghai Zhongshan Hospital
Observational
75
Shanghai
2026-06
Recruiting
Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS
NCT07616037PCOS (Polycystic Ovary Syndrome)
Shanghai Zhongshan Hospital
Phase 2
30
Shanghai
2026-06
Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of Teclistamab in Combination With Daratumumab (Tec-Dara) in Newly Diagnosed Multiple Myeloma With Concurrent Light Chain Amyloidosis (MM+AL).
NCT07638683Multiple Myeloma, AL Amyloidosis
Shanghai Zhongshan Hospital
Phase 2
30
Shanghai
2026-05-22
Not yet open
Safety and Efficacy of High-Channel Implanted BCI for Motor Function Improvement in Tetraplegia Patients
NCT07457645Tetraplegic Motor Dysfunction Following Brainstem or Spinal Cord Injury
Shanghai Zhongshan Hospital
Not applicable
10
Shanghai
2026-05-15
Recruiting
A Single Dose, Dose Escalation Clinical Trial on the Safety, Tolerability and Efficacy of Lyophilized Powder for Inhalation of Recombinant Human Keratinocyte Growth Factor-2 (Rh-KGF-2) in The Treatment of Patients With Acute Respiratory Distress Syndrome
NCT07558538ARDS (Moderate or Severe), ARDS (Acute Respiratory Distress Syndrome)
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
24
Shanghai
2026-05-14
Recruiting
Association Between Chronic Psychological Stress and Disease Course Outcomes in Pancreatic Cancer
NCT07529626Pancreatic Tumor, Benign, Pancreatic Cancer, Adult, Pancreatic Cancer Resectable
Shanghai Zhongshan Hospital
Observational
320
Changsha, Shanghai, Xiโ€™an
2026-05-11
Recruiting
Impact of Hyperemic State on Angio-IMR Performance
NCT07613996Coronary Artery Disease, Microvascular Coronary Artery Disease
Shanghai Zhongshan Hospital
Observational
192
Shanghai, Guangzhou
2026-05-04
Recruiting
Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer
NCT07614061Biliary Tract Neoplasms, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic, Cholangiocarcinoma, Perihilar
Shanghai Zhongshan Hospital
Phase 1
18
Shanghai
2026-05
Not yet open
Inhaled Nitric Oxide for Prevention of Postoperative AKI in High-Risk Cardiac Surgery Patients
NCT07544147Cardiac Surgery Associated - Acute Kidney Injury, Cardiac Surgery With Cardiopulmonary Bypass
Shanghai Zhongshan Hospital
Not applicable
330
Shanghai
2026-04-30
Not yet open
Safety and Preliminary Efficacy of hUCMSC-EVs in Interstitial Lung Disease
NCT07570836Interstitial Lung Disease (ILD)
Shanghai Zhongshan Hospital
Phase 1
24
Shanghai
2026-04-30
Not yet open
Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery
NCT07521787Cardiac Surgery Associated - Acute Kidney Injury, Critical Illness
Shanghai Zhongshan Hospital
Observational
540
Shanghai
2026-04-23
Not yet open
A Clinical Study on the Effect of Massaging Tian Tu Acupoint on Coughing After Esophageal Surgery
NCT07518680Esophageal Neoplasms
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2026-04-10
Recruiting
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes
NCT07528105T1DM - Type 1 Diabetes Mellitus
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
9
Shanghai
2026-04
Not yet open
Accelerated LBBP for Patients With RHF and Severe TR
NCT07470047Right Heart Failure
Shanghai Zhongshan Hospital
Not applicable
24
Nanchang, Shanghai
2026-03-10
Recruiting
Chidamide Combined With Chemotherapy and Immunotherapy as First-line Treatment for Advanced Intrahepatic Cholangiocarcinoma
NCT07570849Intrahepatic Cholangiocarcinoma
Shanghai Zhongshan Hospital
Phase 2
35
Shanghai
2026-03-01
Not yet open
Fecal Molecular Susceptibility-guided Hp First-line Therapy
NCT07405684HELICOBACTER PYLORI INFECTIONS
Shanghai Zhongshan Hospital
Phase 4
544
Shanghai
2026-02-28
Not yet open
Fecal Molecular Susceptibility-guided Hp Rescue Therapy
NCT07405697Helicobacter Pylori Infection
Shanghai Zhongshan Hospital
Phase 4
290
Shanghai
2026-02-28
Recruiting
Gelaspan vs Crystalloid Therapy in Sepsis
NCT07172451Sepsis, Intra-Abdominal Infections
Shanghai Zhongshan Hospital
Phase 4
318
Guangzhou, Nanjing, Suzhou, Xuzhou, Shanghai, Chengdu, Tianjing, Hangzhou
2026-02-13
Not yet open
Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2)
NCT07383142Thymic Epithelial Tumor
Shanghai Zhongshan Hospital
Not applicable
202
Shanghai
2026-02-01
Recruiting
DCB vs DES for Severe Coronary Calcification After Optimal Modification Assessed by QFR
NCT07277114Coronary Calcification
Shanghai Zhongshan Hospital
Not applicable
656
Shanghai
2026-02-01
Recruiting
Efficacy of Montelukast on STEMl Patients
NCT07320625Myocardial Infarction (MI)
Shanghai Zhongshan Hospital
Phase 3
512
Dalian, Shanghai, Fuzhou, Guangdong, Haโ€™erbin, Hefei, Hunan, Shenyang
2026-02-01
Recruiting
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
NCT06794073Carcinoma, Hepatocellular, Neoplasms, Glandular and Epithelial, Adenocarcinoma, Digestive System Neoplasms
Shanghai Zhongshan Hospital
Not applicable
17
Shanghai
2026-01-31
Not yet open
The Effectiveness and Safety of Artificial Intelligence(AI)-Assisted Medical Treatment Decision Support System Compared to Conventional Care in HFrEF Patients
NCT07380555Heart Failure With Reduced Ejection Fraction (HF-rEF)
Shanghai Zhongshan Hospital
Not applicable
1,200
Shanghai
2026-01-30
Recruiting
In Vivo CAR-T for Refractory Graves' Disease
NCT07333677Graves' Disease
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
5
Shanghai
2026-01-29
Recruiting
Treatment Outcomes for Portal Hypertension Esophageal and Gastric Varices
NCT07358663Esophagogastric Varices, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,384
Shanghai
2026-01-20
Not yet open
A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer
NCT07333573Stage IV Gastric Cancer
Shanghai Zhongshan Hospital
Phase 1/2
42
Shanghai
2026-01-01
Not yet open
Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer
NCT07346807Tongue Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
69
Shanghai
2026-01-01
Not yet open
Prevention and Treatment of Early Postoperative Atelectasis Using The MetaNeb System in Patients Underwent Esophagectomy
NCT07284056Atelectases, Postoperative Pulmonary
Shanghai Zhongshan Hospital
Not applicable
178
Shanghai
2026-01-01
Recruiting
Very Early PCSK9 Inhibition for Acute Myocardial Infarction
NCT07208006Acute Myocardial Infarction (AMI)
Shanghai Zhongshan Hospital
Not applicable
1,518
Shanghai
2026-01-01
Not yet open
Feasibility of Circulating Tumor DNA Based Minimal Residual Disease-Guided Adjuvant Therapy in Locally Advanced Gastric Cancer With Neoadjuvant Treatment: An Adaptive Trial (MRD-ATLAS)
NCT07257380Gastric / Gastroesophageal Junction Adenocarcinoma
Shanghai Zhongshan Hospital
Phase 2
90
Shanghai
2025-12-30
Recruiting
Allogeneic Anti-CD19/BCMA CAR-T for Refractory Graves' Disease
NCT07261345Graves' Disease
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
4
Shanghai
2025-12-19
Recruiting
A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data
NCT07561814Pancreatic Cancer
Shanghai Zhongshan Hospital
Observational
1,030
Shanghai
2025-12-09
Recruiting
Asiaticoside for Treating Overweight/Obesity
NCT07241533Overweight , Obesity
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2025-12-01
Not yet open
A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST
NCT07208526Intrahepatic Cholangiocarcinoma (Icc), Conversion Therapy, TDTP-RECIST, GOLP Regimen
Shanghai Zhongshan Hospital
Not applicable
270
Shanghai
2025-12-01
Recruiting
Valsalva SBP Drop and LVOT Obstruction
NCT07483125HCM, oHCM, nHCM
Shanghai Zhongshan Hospital
Observational
800
Shanghai
2025-12-01
Not yet open
EFG vs IVIG in TAMG
NCT07231523Efgartigimod, Intravenous Immunoglobulin, Myasthenia Gravis Associated With Thymoma
Shanghai Zhongshan Hospital
Phase 3
64
Shanghai
2025-12-01
Recruiting
Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms
NCT07272512Neuroendocrine Tumors, Neuroendocrine Neoplasms
Shanghai Zhongshan Hospital
Phase 4
350
Shanghai
2025-11-11
Recruiting
Construction of a Portal Hypertension Biobank
NCT07419724Variceal Bleeding, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,000
Shanghai
2025-10-16
By invitation
Autologous Islet Transplantation for Diabetes
NCT07118475Diabetes Mellitus, Type 2
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
24
Shanghai
2025-10-07
Active, closed
A Novel Strategy for Endoscopic Dual-instrument Retrieval of Upper GI Foreign Body
NCT07649382Foreign Body Ingestion
Shanghai Zhongshan Hospital
Observational
10
Shanghai
2025-10-01
Active, closed
A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy
NCT07176702Metastatic PDAC, HER2-positive Status
Shanghai Zhongshan Hospital
Phase 2
45
Nanjing, Shanghai
2025-09-30
Recruiting
High-Resolution CT for Heart
NCT07169201Coronary Artery Disease
Shanghai Zhongshan Hospital
Observational
500
Shanghai
2025-09-01
Not yet open
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection
NCT07156656Type A Aortic Dissection, Organ Failure, Multiple
Shanghai Zhongshan Hospital
Phase 4
236
Hefei, Fuzhou, Guangzhou, Shenzhen, Xi'an, Shanghai
2025-09-01
Recruiting
High Flow Nasal Cannula and Mask Oxygenation in Patients With Visceral Obesity Undergoing Sedated Gastroscopy
NCT07159022High Flow Nasal Cannula, Body Roundness Index
Shanghai Zhongshan Hospital
Not applicable
200
Shanghai
2025-08-31
Recruiting
ยตQFR for Branch Stenosis After Single Stent in Bifurcation Lesions
NCT07116083Coronary Artery Disease, Coronary Artery Disease (Left Main), Obstructive Coronary Artery Disease, Stent Implantation
Shanghai Zhongshan Hospital
Observational
290
Shanghai
2025-08-13
Recruiting
Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease
NCT07129642Graves Disease
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
5
Shanghai
2025-08-10
Not yet open
Observational Analysis of the Associational Between Dietary Factors and Postprandial Glucose Fluctuations
NCT07117188Diabetes
Shanghai Zhongshan Hospital
Observational
48
Shanghai
2025-08-05
Recruiting
Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Libertyยฎ Flex Transcatheter Aortic Valve Delivery System for the Treatment of Severe Aortic Stenosis Lesions
NCT07145463Aortic Valve Stenosis
Shanghai Zhongshan Hospital
Not applicable
232
Shanghai
2025-07-30
Recruiting
Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)
NCT07317609Esophageal Squamous Cell Carcinoma (ESCC)
Shanghai Zhongshan Hospital
Phase 1
60
Shanghai
2025-07-15
Active, closed
EndoVascular Aortic Dissection Early vs Delayed
NCT07143071Aortic Dissection Type B
Shanghai Zhongshan Hospital
Observational
4,068
Shanghai
2025-07-01
Recruiting
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
NCT07309289Metastatic Colorectal Cancer (CRC)
Shanghai Zhongshan Hospital
Phase 3
144
Shanghai
2025-07-01
Recruiting
REsiduAL rISk Under Intensive Lipid-lowering Therapy In Coronary Heart Disease
NCT06936111Coronary Heart Disease (CHD)
Shanghai Zhongshan Hospital
Observational
900
Shanghai
2025-07-01
Not yet open
Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
NCT07079410Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma, Resectable Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
50
Shanghai
2025-07
Recruiting
An Exploratory Clinical Study of HRS-4642 in Combination With Immunotherapy and Chemotherapy for Pancreatic Cancer
NCT06938282Pancreatic Cancer
Shanghai Zhongshan Hospital
Phase 2
60
Shanghai
2025-06-23
Not yet open
RCT of Minimalist vs Standard Procedure for LAAC in NVAF Patients
NCT06969118Atrial Fibrillation, Left Atrial Appendage Occlusion, General Anesthesia, Local Anesthesia
Shanghai Zhongshan Hospital
Not applicable
200
Shanghai
2025-06-01
Not yet open
Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment๏ผšan Open-label, Randomized, Controlled Phase II Clinical Study
NCT06946849Intrahepatic Cholangiocarcinoma (Icc)
Shanghai Zhongshan Hospital
Phase 2
76
Shanghai
2025-06-01
Recruiting
Efficacy of Dihydroartemisinin for Treating Female Androgenetic Alopecia
NCT07012486Androgenetic Alopecia (AGA)
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
30
Shanghai
2025-06
Recruiting
Efficacy of Dihydroartemisinin for Treating Acne Vulgaris
NCT07007078Acne Vulgaris
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
60
Shanghai
2025-06
Recruiting
IndObufen Versus asPirin After Coronary Drug-eluting Stent implantaTION in Elderly Patients With Acute Coronary Syndrome
NCT06451198Coronary Artery Disease, Antiplatelet Drugs
Shanghai Zhongshan Hospital
Phase 4
2,846
Shanghai
2025-05-19
Not yet open
A Study of SHR-1826 Monotherapy or in Combination With Immunotherapy in the Treatment of Advanced Hepatocellular Cancer
NCT06935175Hepatocellular Cancer
Shanghai Zhongshan Hospital
Phase 2
53
Shanghai
2025-05-01
Recruiting
Sleep Disorders and Tumor Immune Microenvironment
NCT06941948Impact of Sleep Disorders on Tumor Immune Microenvironment and Clinical Outcomes in Lung Cancer
Shanghai Zhongshan Hospital
Observational
400
Shanghai
2025-05-01
Not yet open
Evaluate the Clinical Feasibility of a Novel Neoantigen-Reactive CD8+ T Cell (NART) Detection Technology for Postoperative MRD Surveillance of Pancreatic Cancer
NCT06941987Minimal Residual Disease, Pancreatic Cancer Resectable
Shanghai Zhongshan Hospital
Observational
66
Shanghai
2025-04-20
Recruiting
Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome
NCT06842524Polycystic Ovary Syndrome (PCOS)
Shanghai Zhongshan Hospital
Phase 2
150
Xiamen, Shanghai, Wenzhou
2025-04-16
Active, closed
Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes
NCT06991829Diabetes Mellitus
Shanghai Zhongshan Hospital
Phase EARLY_PHASE1
29
Shanghai
2025-04-03
Recruiting
The Safety and Effectiveness of Hyperthermic Intraperitoneal Chemotherapy Combined With Intravenous Chemotherapy for Peritoneal Metastatic Pancreatic Cancer, a Phase II Clinical Trial
NCT06946901Hyperthermic Intraperitoneal Chemotherapy, Peritoneal Metastatic Pancreatic Cancer
Shanghai Zhongshan Hospital
Phase 2
90
Changsha, Shanghai
2025-04-03
Active, closed
Acute Myocardial Infarction Clinical Cohort
NCT07522164Acute Myocardial Infarction
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2025-04-01
Recruiting
Correction of Anemia With Enarodustat in Non-dialysis Dependent Chronic Kidney Disease
NCT06725810Chronic Kidney Disease Associated Anemia
Shanghai Zhongshan Hospital
Phase 4
1,670
Shanghai
2025-03-27
Not yet open
Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer
NCT05562297Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB, Pancreatic Cancer Stage III
Shanghai Zhongshan Hospital
Phase 2
50
Shanghai
2025-03-20
Recruiting
Improve the Strategies of Endoscopic and Interventional Treatment of Gastroesophageal Hemorrhage in Portal Hypertension
NCT06970509Esophageal Varices, Portal Hypertension
Shanghai Zhongshan Hospital
Observational
1,450
Guangzhou, Nanchang, Shenyang, Jinan, Shanghai
2025-03-01
Recruiting
Exploring Clinical Characteristics of Liver Disease Patients Based on Digestive Metabolic Exhaled Air
NCT06968234Cirrhosis, Microbiota, Breath Tests
Shanghai Zhongshan Hospital
Observational
1,000
Shanghai
2025-03-01
Recruiting
Patient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
NCT07054086Esophageal Cancer
Shanghai Zhongshan Hospital
Observational
30
Shanghai
2025-03-01
Recruiting
Evaluation of the Efficacy and Safety of Fecal Microbiota Transplantation for Constipation in Parkinson's Disease
NCT06388863Parkinson Disease
Shanghai Zhongshan Hospital
Not applicable
76
Shanghai
2025-02-21
Recruiting
Camrelizumab Combined With Rivoceranib and Hepatic Arterial Infusion Chemotherapy (HAIC) as Conversion Therapy for Potentially Resectable Hepatocellular Carcinoma(HCC)
NCT06796803Potentially Resectable Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Phase 2/3
398
Harbin, Shanghai
2025-02-20
Recruiting
Effect of Low Valine Diet on Body Weight and Metabolic Parameters
NCT06883578Overweight/obesity, Metabolic Associated Fatty Liver Disease, Metabolic Diseases
Shanghai Zhongshan Hospital
Not applicable
48
Shanghai
2025-02-18
Not yet open
Study on the Correlation Between Tracheotomy Tip Pressure and Esophageal Pressure in Patients Weaned from Tracheotomy
NCT06783777Respiratory Distress Syndrome (RDS), Respiratory Ilness
Shanghai Zhongshan Hospital
Not applicable
42
Shanghai
2025-02-05
Not yet open
Chemoradiotherapy in Elderly Patients with Locally Advanced Pancreatic Cancer (70+).
NCT06844773Unresectable Locally Advanced Pancreatic Cancer
Shanghai Zhongshan Hospital
Observational
36
Shanghai
2025-02
Recruiting
Combined Coronary CT Angiography and CT Perfusion in Coronary Artery Disease (CoroFusion)
NCT06949150Coronary Arterial Disease (CAD)
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2025-01-01
Active, closed
IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma
NCT06757881HCC
Shanghai Zhongshan Hospital
Phase 1
3
Shanghai
2025-01-01
Not yet open
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
NCT06728618Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC), Resectable Oral and Oropharyngeal Squamous Cell Carcinoma, Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
28
Shanghai
2024-12
Recruiting
A Study of HRS-4642 Monotherapy or in Combination With Adebrelimab in the Treatment of Advanced Biliary Tract Tumors.
NCT06620848Biliary Tract Cancer
Shanghai Zhongshan Hospital
Phase 2
49
Shanghai
2024-11-21
Recruiting
Physiological Effects and Safety of Continuous High-frequency Oscillatory Ventilation in Mechanical Ventilation Patients
NCT06662630Atelectasis, Acute Respiratory Distress Syndrome, VAP - Ventilator Associated Pneumonia
Shanghai Zhongshan Hospital
Not applicable
30
Shanghai
2024-11-19
Recruiting
Physiological Effects and Safety of Continuous High-frequency Oscillatory Ventilation in ICU Patients
NCT06702813Atelectasis, Postoperative, Hypoxia, Critical Illness
Shanghai Zhongshan Hospital
Not applicable
45
Shanghai
2024-11-19
Rows per page Showing 1–100 of 163
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 163 of those studies with a site in Shanghai that also match the filters currently applied.

How many clinical trials are recruiting in Shanghai?

93 of the 163 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 51 have not yet opened recruitment, 15 are active but closed to new participants, and 4 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shanghai), 163 studies
PhaseStudiesRecruitingShare
Observational533332.5%
Not applicable442427%
Phase 2311619%
Phase 41277.4%
Phase EARLY_PHASE1975.5%
Phase 1422.5%
Phase 2/3422.5%
Phase 3422.5%
Phase 1/2201.2%

Most active sponsors

Lead sponsors with the most studies (Shanghai)
Lead sponsorStudiesRecruiting
Shanghai Zhongshan Hospital16393
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.